This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Xigen Inflammation Ltd., Brightpulse Holding Ltd., Ribovax Biotechnologies S.a.. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 14 
1 out of 1 
1 out of 6 Years Active: 2014-2021
Title: Claire Abadie: Innovator in Ocular Therapeutics
Introduction
Claire Abadie is a prominent inventor based in Annecy, France, known for her significant contributions to the field of ocular therapeutics. With a total of four patents to her name, she has focused her research on innovative treatments for inflammatory eye diseases. Her work has the potential to greatly impact the lives of individuals suffering from various ocular conditions.
Latest Patents
One of Claire Abadie's latest patents involves the use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases. This invention refers to the use of protein kinase inhibitors, specifically targeting the c-Jun amino terminal kinase (JNK) with (poly-)peptides, chimeric peptides, or nucleic acids encoding these inhibitors. The patent outlines pharmaceutical compositions that can treat a range of inflammatory diseases affecting the eye, including hordeolum, chalazion, conjunctivitis, keratitis, and uveitis, among others. Another notable patent focuses on the protein SLURP-1 for use in the treatment of ocular diseases. This invention relates to a protein comprising SEQ ID NO:1 (the mature form of SLURP-1) and its composition for inducing or accelerating cicatrization and preventing infection in the eye.
Career Highlights
Throughout her career, Claire Abadie has worked with various companies, including Xigen Inflammation Ltd. and Ribovax Biotechnologies S.A. Her innovative research and dedication to improving ocular health have established her as a key figure in the biotechnology sector.
Collaborations
Claire has collaborated with notable professionals in her field, including Jean-Marc Combette and Catherine Deloche. These partnerships have further enhanced her research and development efforts in ocular therapeutics.
Conclusion
Claire Abadie is a trailblazer in the field of ocular therapeutics, with her patents paving the way for new treatments for inflammatory eye diseases. Her contributions to the industry reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile